Jefferies Boosts Price Target on Tenet Healthcare (THC) to $6.50

Jefferies raised its price target on Buy-rated Tenet Healthcare (NYSE: THC) earlier from $6 to $6.50.

The firm comments, "We do not expect the departure of CFO Biggs Porter to Fluor to disrupt THC's strategic focus, particularly since CEO Trevor Fetter is assuming the CFO role on an interim basis. We are updating our FY12 and FY13 earnings forecasts. Maintaining Buy/$6.50PT (up from $6)."

The firm cut FY12 EPS from $0.52 to $0.50.

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $5.43 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
• Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
• Terreno Realty Corp (TRNO) PT Raised to $77 at Cantor Fitzgerald on Leasing Optimism